pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 29·1 min read
save

AI researcher Kyunghyun Cho leaves Genentech to explore pharma applications at Endpoints AI Day

Apr 29, 2026·read at Endpoints ↗Positive

Kyunghyun Cho, a noted AI researcher, announced that he has left Genentech to pursue independent work in pharmaceutical applications of machine learning.

He will discuss his new focus at Endpoints AI Day 2024, held in Rio de Janeiro, where he reviewed numerous poster presentations on AI and drug discovery.

Cho’s move highlights the increasing enthusiasm within the pharma sector for larger AI investments as companies look to accelerate research and development through advanced computational tools.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Should pharma be swinging bigger with AI? One top researcher wants to try”

read at Endpoints ↗
100 words · retrieved Apr 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GENENTECH

related stories

  • 4d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Aug 24Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drugBioSpace
  • Aug 24Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismFierce Biotech
  • Aug 21Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trialEndpoints
  • Aug 21STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and moreSTAT